🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Spain
Clinical trial register · Spain

Studies with a Spanish investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5885 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:52 UTC
5885
Studies in scope
all four open statuses
3103
Recruiting now
open to new participants
1139
Lead sponsors
across recruiting studies
Top sites
Barcelona 3233 Madrid 3015 Valencia 1201 Seville 1055 Málaga 741
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca221 Novartis Pharmaceuticals152 Merck Sharp & Dohme LLC133 Janssen Research & Development, LLC124 Hoffmann-La Roche124
Site location
Barcelona3233 Madrid3015 Valencia1201 Seville1055 Málaga741
All 455 locations
Target enrolment
to

Trials in this register

5885 of 5885 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Active, closed
Robot Asissted Training on Neurodevelopmental Alterations
NCT06645795Neurodevelopmental Disorders, Cerebral Palsy
University of Valencia
Not applicable
9
Valencia
2024-10-17
Active, closed
Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer
NCT06667752Diabetic Foot Ulcer, Diabetic Foot Infection
Nanordica Medical OU
Not applicable
136
Arcos de la Frontera, Cadiz, Jerez de la Frontera, León, Madrid, San Sebastián
2024-10-17
Active, closed
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)
NCT06643481Amyotrophic Lateral Sclerosis (ALS)
DrugVHB937
Novartis Pharmaceuticals
Phase 2
251
Santiago Compostela, L'Hospitalet de Llobregat, Barcelona, Valencia
2024-10-17
Active, closed
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
NCT05888922Androgenetic Alopecia, Female Pattern Baldness
DrugMinoxidil
Industrial Farmacéutica Cantabria, S.A.
Phase 3
520
Barcelona, Madrid, Valencia
2024-10-17
Active, closed
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
NCT06598462Eosinophilic Esophagitis (EoE)
DrugSolrikitug
Uniquity One (UNI)
Phase 2
184
Barcelona, Madrid, Tomelloso
2024-10-16
Recruiting
Aut-CARE Intervention to Improve Cognitive and Emotional Functioning in Young Adults on the Autism Spectrum
NCT07041502Autism Spectrum Disorder, Autism Spectrum Disorder With Absence of Functional Language
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Observational
37
Barcelona
2024-10-16
Active, closed
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
NCT06625320Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
DrugsRMC-6236·Liposomal Irinotecan·Leucovorin·Adrucil
Revolution Medicines, Inc.
Phase 3
500
Barcelona, Madrid, Pamplona, Valencia
2024-10-16
Recruiting
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
NCT06641089Arthritis, Psoriatic
DrugsSonelokimab·Risankizumab
MoonLake Immunotherapeutics AG
Phase 3
600
A Coruña, Alcobendas, Bilbao, Castellon, Madrid, Málaga, Sabadell, Santiago de Compostela
2024-10-15
Active, closed
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
NCT06823713End-stage Liver Disease (ESLD), Cirrhosis, Liver, Cirrhosis, Decompensated, Liver Diseases
Resolution Therapeutics Limited
Phase 1/2
30
Barcelona, Córdoba, Madrid, Seville
2024-10-15
Recruiting
Ultrasound to Check the Position of the Nasogastric Tube
NCT06635915Nasogastric Tube Placement
Hospital Universitario de Gran Canaria Doctor Negrín
Not applicable
114
Palmas de GRAN Canaria, LAS, Las Palmas de Gran Canaria
2024-10-15
Recruiting
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
NCT06663319Colorectal Neoplasms, Gastrointestinal Neoplasms
DrugsFolfiri·Folfox·Bevacizumab
Janssen Research & Development, LLC
Phase 1
260
Barcelona, Madrid
2024-10-15
Not yet open
Adjunctive Use of Polynucleotide and Hyaluronic Acid-based Gel in Alveolar Preservation After Tooth Extraction
NCT06633211Bone Substitutes, Tooth Extraction Status Nos
Adrià Jorba García
Not applicable
20
Barcelona
2024-10-15
Active, closed
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug
NCT06641076Arthritis, Psoriatic
DrugSonelokimab
MoonLake Immunotherapeutics AG
Phase 3
960
A Coruña, Alcobendas, Bilbao, Castelló, Madrid, Málaga, Sabadell, Santiago de Compostela
2024-10-15
Recruiting
Study of ATX-01 in Participants With DM1
NCT06300307Myotonic Dystrophy 1
ARTHEx Biotech S.L.
Phase 1/2
56
Donostia / San Sebastian
2024-10-15
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT06562192Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, HR+/HER2- Ductal and Lobular Breast Cancer, Triple Negative Breast Cancer
Novartis Pharmaceuticals
Phase 1
162
Barcelona, Madrid
2024-10-15
Active, closed
A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)
NCT06504394Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory, Primary Mediastinal Large B-cell Lymphoma Recurrent, Primary Mediastinal Large B-cell Lymphoma Refractory
Drugs) Berahyaluronidase alfa·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 2
66
L'Hospitalet Del Llobregat, Salamanca, Madrid
2024-10-14
Recruiting
Early Atrial Fibrillation Ablation for Stroke Prevention in Patients With High Comorbidity Burden (EASThigh-AFNET 11)
NCT06324188Atrial Fibrillation
Atrial Fibrillation Network
Not applicable
2,312
Multiple Locations
2024-10-14
Active, closed
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)
NCT06553768Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
DrugMaralixibat
Mirum Pharmaceuticals, Inc.
Phase 3
90
Barcelona, Madrid
2024-10-14
Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Boehringer Ingelheim
Phase 3
1,800
A Coruña, Barcelona, Córdoba, Madrid, Majadahonda, Pontevedra, Santander, Santiago de Compostela
2024-10-14
Recruiting
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
NCT06447168Primary Biliary Cholangitis
Ipsen
Observational
424
Almería, Barcelona, Madrid, Pontevedra, Santander
2024-10-14
Recruiting
Clinical Epidemiology in Contemporary Patients With Myelofibrosis.
NCT06533813Myelofibrosis
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
617
Barcelona, Madrid
2024-10-14
Recruiting
Ultrasound Assessment After Surgery for Chronic Anal Fissure
NCT07809711Anal Fissure Chronic
Hospital Clínico Universitario de Valencia
Observational
66
Valencia
2024-10-12
Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
NCT06581432Solid Tumours
DrugZongertinib
Boehringer Ingelheim
Phase 2
588
A Coruña, Badalona, Barcelona, Madrid, Pamplona, Seville, Valencia
2024-10-11
Active, closed
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
NCT06388564Chronic Graft-versus-host-disease
DrugsAxatilimab·Prednisolone·Ruxolitinib·Methylprednisolone
Incyte Corporation
Phase 2
130
Barcelona, El Palmar, Granada, Granvia de L'hospitalet 199-203, Madrid, Málaga, Salamanca, Santander
2024-10-11
Recruiting
A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy
NCT05460000Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Clear Cell Carcinoma
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Alicante, Granada, Lugo, Madrid, Manresa, Seville, Tarragona, Valencia
2024-10-11
Recruiting
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
NCT06446882HER2-positive Breast Cancer, Early-stage Breast Cancer
Fundacio Clinic Barcelona
Not applicable
304
L'Hospitalet de Llobregat, Granada, Santiago de Compostela, León, Madrid, Murcia, Reus, Bilbao
2024-10-11
Recruiting
Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry
NCT06620757Atrial Fibrillation
Fundación EPIC
Observational
234
A Coruña, Aravaca, Barcelona, Córdoba, Fuencarral-El Pardo, Gijón, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria
2024-10-10
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
NCT06598943Ulcerative Colitis, Ulcerative Colitis Chronic
DrugsEltrekibart·Mirikizumab
Eli Lilly and Company
Phase 2
143
Barcelona, Ciudad Real, Córdoba, Huelva, Las Palmas de GC, Madrid, Santiago de Compostela, Seville
2024-10-10
Active, closed
Efficacy of Focused Shock Wave Therapy Before and After Botulinum Toxin Injection in Patients With Post-Stroke Spastic Equinus/Equinovarus Foot: A Randomized Clinical Trial
NCT07758322Post-Stroke Spasticity, Spastic Equinovarus Foot
DrugsOnabotulinumtoxinA·Botulinum toxin type A
María Belén Martínez Luna
Not applicable
69
Madrid
2024-10-10
Active, closed
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
NCT06516965Prurigo Nodularis
DrugPovorcitinib
Incyte Corporation
Phase 3
346
Alicante, Badalona, Barcelona, Córdoba, Granada, Madrid, Majadahonda, Manises
2024-10-10
Active, closed
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
NCT06625060Episodic Migraine, Chronic Migraine
DrugCorabotase
Ipsen
Phase 2
670
Barcelona, Cadiz, Madrid, Santander, Seville, Valladolid
2024-10-10
Recruiting
Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.
NCT06423898Endocarditis, Infective
DrugAmpicillin
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 4
284
Alava, Barakaldo, Barcelona, Donostia / San Sebastian, Granada, Logroño, Madrid, Málaga
2024-10-09
Recruiting
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
NCT06525636X-linked Hypophosphatemia
Kyowa Kirin Co., Ltd.
Phase 1/2
39
Madrid
2024-10-09
Active, closed
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
NCT05417789TGCT
DrugEmactuzumab
SynOx Therapeutics Limited
Phase 3
128
Zaragoza, Barcelona, Seville, Valencia
2024-10-09
Active, closed
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
NCT06630286HIV-1-infection
DrugsISL/LEN·B/F/TAF
Gilead Sciences
Phase 3
609
A Coruña, Barcelona, Málaga
2024-10-09
Recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
NCT06470048Diffuse Cutaneous Systemic Sclerosis
DrugIanalumab
Novartis Pharmaceuticals
Phase 2
200
Málaga, Valencia, Barcelona, Madrid, Salamanca
2024-10-09
Active, closed
Evaluation of First Year Implementation of Komtü Programme to Improve Emotional Well-being in School.
NCT06488833Psychological Well-Being, Mental Health Wellness
Universitat Autonoma de Barcelona
Not applicable
270
Barcelona
2024-10-08
Active, closed
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
NCT06335979Systemic Lupus Erythematosus, SLE
DrugPIT565
Novartis Pharmaceuticals
Phase 1
54
Santiago Compostela, Barcelona, Madrid
2024-10-08
Recruiting
Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.
NCT06660446Lymphoma
Biogipuzkoa Health Research Institute
Not applicable
180
Vitoria - Gateiz, Galdakao, San Sebastián
2024-10-08
Active, closed
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
NCT06630299HIV-1-Infection
DrugsAntiretroviral Combinations·ISL/LEN
Gilead Sciences
Phase 3
600
Barcelona, Madrid, Seville
2024-10-08
Not yet open
Effects of a Supervised Training Program on Functional Capacity in Patients With HF and Cardiorenal Syndrome
NCT06640140Heart Failure, Cardiorenal Syndrome
Fundación para la Investigación del Hospital Clínico de Valencia
Not applicable
26
Valencia
2024-10-08
Recruiting
Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy
NCT06730464Dilated Cardiomyopathy, Arrhythmogenic Cardiomyopathy, Ventricular Arrhythmia, Hypertrophic Cardiomyopathies
Centro Medico Teknon
Observational
500
Barcelona, Seville
2024-10-07
Active, closed
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors
NCT06631079Solid Tumor
NEC Bio B.V
Phase 1/2
20
Barcelona, Madrid, Santiago de Compostela
2024-10-07
Recruiting
Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acute Coronary Syndrome Without ST Elevation
NCT06695429Non ST Segment Elevation Acute Coronary Syndrome, Contrast Induced Nephropathy
Hospital General Universitario Santa Lucia
Not applicable
130
Cartagena
2024-10-07
Recruiting
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
NCT06602479Migraine
AbbVie
Phase 2
488
Badajoz, Barcelona, Madrid, Valencia
2024-10-07
Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
NCT06598306Extensive Stage Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 1
220
Málaga, Barcelona, Valencia, Madrid
2024-10-07
Recruiting
Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volunteers
NCT06841458Androgenetic Alopecia
Industrial Farmacéutica Cantabria, S.A.
Not applicable
45
Valencia
2024-10-07
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
NCT06561386Non-small Cell Lung Cancer
DrugsRelatlimab·Pemetrexed·Nivolumab·Cisplatin
Bristol-Myers Squibb
Phase 3
1,000
A Coruña, Barcelona, L'Hospitalet de Llobregat, Palma, Madrid, Majadahonda, Valencia, Málaga
2024-10-07
Active, closed
Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer
NCT06097078Esophageal Cancer, Esophagus Cancer, Anastomotic Leak
Aesculap AG
Observational
44
Barcelona
2024-10-07
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Barakaldo, Madrid
2024-10-05
Recruiting
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT06417814Metastatic Non-small Cell Lung Cancer
DrugsTagrisso·Datopotamab Deruxtecan·Osimertinib·Pemetrexed
AstraZeneca
Phase 3
744
A Coruña, Barakaldo, Barcelona, El Palmar, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga
2024-10-04
Recruiting
CENP-V as a Potential Diagnostic Marker of Damage in Human Oocytes
NCT06788379Establish the Amount of CENPV Protein in Human Oocytes as a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes, Advance Maternal Age, Vitrification and Thawing
Vida Recoletas Sevilla
Observational
160
Seville
2024-10-04
Recruiting
Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients
NCT06634199Non-small Cell Lung Cancer Stage III, PDL1 Gene Mutation
DrugDurvalumab
Fundación GECP
Observational
50
Ferrol, Alicante, Badalona, Barcelona, Bilbao, Ciudad Real, Girona, A Coruña
2024-10-03
Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
NCT05947955Acute Respiratory Distress Syndrome, Infections
BioAegis Therapeutics Inc.
Phase 2
600
Barcelona, Madrid, Tarragona
2024-10-03
Recruiting
A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
NCT06578078Heart Failure, Chronic Kidney Diseases
DrugSodium Zirconium Cyclosilicate
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 3
94
Alcorcón, Leganés, Albacete, Burgos, Córdoba, Valencia
2024-10-03
Active, closed
Virtue-Based vs. Cognitive-Behavioral Interventions in Patients With Chronic Medical Disease
NCT06501235Well-Being, Psychological
University of Valencia
Not applicable
100
Valencia
2024-10-02
Recruiting
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
NCT06684379SARS-CoV-2, Influenza, Human, Respiratory Syncytial Virus Infections, Respiratory Distress Syndrome
PEACHES BIOTECH
Phase 1/2
50
Alcalá de Henares, Fuenlabrada, Córdoba
2024-10-02
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
NCT06568237Multiple System Atrophy
DrugTEV-56286
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
350
Barakaldo, Barcelona, Elche, Madrid, Pamplona, Seville, Valencia
2024-10-02
Active, closed
The Post Intensive Care Syndrome Follow-up and Management Study: The ICU Recovery Answers Project
NCT06504979Post Intensive Care Syndrome, ICU Survivors, ICU Families
Corporacion Parc Tauli
Not applicable
360
Sabadell
2024-10-02
Not yet open
Clinical and Endoscopic Characterization of Patients With Multiple Colorectal Adenomas: A Multicenter Study in Spain (ESPAPOLYP Study)
NCT06625788Colorectal Cancer Control and Prevention
Asociación Española de Gastroenterología
Observational
200
Madrid
2024-10-01
Not yet open
The Personalized Psychological Treatment for Psychosis
NCT06603922Schizophrenia, Psychosis, Schizophrenia Spectrum and Other Psychotic Disorders
Polish Academy of Sciences
Not applicable
252
Barcelona
2024-10-01
Recruiting
Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome
NCT06918236Fetal Growth Restriction (FGR), Preeclampsia, Stillbirth, Placenta Previa
Aristotle University Of Thessaloniki
Observational
12,084
Santa Cruz de Tenerife, Madrid, Murcia
2024-10-01
Recruiting
Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NCT06207383Atrial Fibrillation, Persistent, Heart Failure
University Hospital, Geneva
Not applicable
220
Madrid
2024-10-01
Not yet open
"Comparison of Shockwave Application on the Sole of the Foot Vs. the Back of the Leg in the Treatment of Plantar Fasciitis: a Clinical Trial."
NCT06589037Plantar Fasciitis
University of Alcala
Not applicable
48
Alcalá de Henares
2024-10-01
Active, closed
Effects of Neurofeedback Training on Attentional Deficits in Patients With Acquired Brain Injury
NCT06863025Brain Injuries, Attention Disorder
Hospitales Nisa
Not applicable
30
Valencia
2024-10-01
Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
NCT06510374Intermediate Risk Non-Muscle Invasive Bladder Cancer
DrugNadofaragene Firadenovec
Ferring Pharmaceuticals
Phase 3
454
Santander, Barcelona, Córdoba, A Coruña, Granada, Alcorcón, Madrid, Bilbao
2024-10-01
Active, closed
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
NCT06506955Advanced/Metastatic Cancer
DrugFutibatinib
Taiho Oncology, Inc.
Phase 2/3
15
Barcelona, Madrid
2024-10-01
Active, closed
SIRAKI 02 Posthoc Analysis.
NCT06781294Cardiac Surgery Requiring Cardiopulmonary Bypass, Acute Kidney Injury, Chronic Kidney Disease(CKD), Kidney Failure, Acute
Hospital Universitari de Bellvitge
Not applicable
343
L'Hospitalet de Llobregat
2024-10-01
Active, closed
Motor-cognitive Training Effects on Cognition in Breast Cancer Survivors: the BRAINonFIT Study (BRAINonFIT).
NCT06073717Breast Cancer Survivors, Cognitive Impairment, Executive Dysfunction
University of Seville
Not applicable
108
Seville
2024-10-01
Recruiting
e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population
NCT06313827Cystic Fibrosis
University of Valencia
Not applicable
60
Valencia
2024-10-01
By invitation
Effectiveness of Online Training in Cardiopulmonary Resuscitation Maneuvers for a Network of Volunteers.
NCT06275984Cardiorespiratory Arrest, Cardiopulmonary Arrest With Successful Resuscitation
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Not applicable
156
Barcelona
2024-10-01
Recruiting
Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme
NCT07658755Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Fibrosis, Non-alcoholic Fatty Liver Disease NAFLD, Type 2 Diabetes Mellitus
Hospital General Universitario Gregorio Marañon
Observational
3,000
Madrid
2024-10-01
Recruiting
Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza
NCT06528444Influenza
Instituto de Investigación Sanitaria y Biomédica de Alicante
Phase 3
42
Alicante, Elche
2024-10-01
Recruiting
Multicenter Trial of Proximal Femoral Guided Growth in Children With CP and Hips at Risk of Dislocation (GGSH-MC)
NCT06956729Cerebral Palsy
Fundación para la investigación biomética Hospital Infantil Universitario Niño Jesús
Not applicable
42
A Coruña, Almería, Seville, Palma, Salamanca, Barcelona, Donostia / San Sebastian, Madrid
2024-10-01
Recruiting
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
NCT06569602Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases
Edwards Lifesciences
Observational
500
Madrid
2024-10-01
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
NCT06545955Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
DrugsNadofaragene Firadenovec·Docetaxel·Gemcitabine·Pembrolizumab
Ferring Pharmaceuticals
Phase 3
250
Santander, Barcelona, Córdoba, A Coruña, Alcorcón, Madrid, Pamplona, Bilbao
2024-10-01
Not yet open
Exercise Effects on Atrial Fibrillation
NCT06607510Atrial Fibrillation
European University Miguel de Cervantes
Not applicable
57
Valladolid
2024-10-01
By invitation
The Role of Executive Functioning in Complex Post-Traumatic Stress Disorder Among Female Survivors of Intimate Partner Violence
NCT06706882Neuropsychological Rehabilitation Program (VIRTRAEL/LUCCIDY), Standard Training (TAU)
Universidad de Granada
Not applicable
80
Granada
2024-10-01
Not yet open
External Body Weight Effects on Body Weight in Adults With Grade II and III Obesity
NCT06619028Obesity Prevention, Obesity
Escoles Universitaries Gimbernat
Not applicable
24
Sant Cugat del Vallès
2024-10-01
Not yet open
ACOMPANYEM: A COMmunity Program Accessing Lonely, Disabled Neighbors (Young, Elder, and Midlife)
NCT06606431Social Isolation or Loneliness, Homebound Persons, Disabled Persons
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Not applicable
8
Tarragona
2024-10-01
Not yet open
Efficacy of Hypopressive Exercises Versus Pilates in Women with Abdominal Diastasis in the Postpartum Period: a Randomized Controlled Trial
NCT06599541Abdominal Diastasis
University of Alcala
Not applicable
48
Fuenlabrada
2024-10
Recruiting
Comparison of Manual Therapy Versus Radial Shock Waves in the Shoulder Pain Treatment
NCT06587399Shoulder Impingement, Shoulder Pain
University of Alcala
Not applicable
88
Alcalá de Henares
2024-09-30
Recruiting
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
NCT05663515Pancreatic Cancer
DrugExenatide
AstraZeneca
Observational
24,000
Barcelona
2024-09-30
Active, closed
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
NCT06473779Severe Asthma
AstraZeneca
Phase 3
326
Badalona(Barcelona), Barcelona, Lugo, Madrid
2024-09-30
By invitation
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients
NCT06657859Pmm2-CDG, Phosphomannomutase 2 Deficiency
Glycomine, Inc.
Phase 2
90
Esplugues de Llobregat, Madrid
2024-09-30
Active, closed
Rehabilitation Gaming System for Intensive Care Units
NCT06267911Critical Illness
University of the Balearic Islands
Not applicable
93
Palma de Mallorca, Sabadell
2024-09-30
Recruiting
Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma
NCT06574126High Risk Smoldering Multiple Myeloma
PETHEMA Foundation
Phase 2
20
Salamanca
2024-09-30
By invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
NCT06609239Asthma
DrugLunsekimig
Sanofi
Phase 2
900
Barcelona, Madrid
2024-09-30
Recruiting
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
NCT06551142Neoplasms
DrugsRis-Rez·Tarlatamab·Dostarlimab·Cetuximab
GlaxoSmithKline
Phase 1
845
Badajoz, Barcelona, Madrid, Málaga, Valencia, Zaragoza
2024-09-30
Recruiting
Influence of Cemented Cephalic Augmentation on the Outcome of Intramedullary Nailing in Pertrochanteric Hip Fractures
NCT06634290Hip Fracture of Intertrochanteric Type
Diego Matías Domínguez Prado
Not applicable
314
Monforte de Lemos, Verín, Vigo, Vilagarcía de Arousa, Ourense, Pontevedra
2024-09-30
Recruiting
First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors
NCT06622486Solid Tumor, Adult
Egle Therapeutics
Phase 1/2
50
Barcelona, Madrid, Pamplona, Valencia
2024-09-27
Recruiting
Effect of Supplementation With Creatine on the Recovery of Ischemic Stroke
NCT06576466Stroke, Ischemic
Fundació d'investigació Sanitària de les Illes Balears
Not applicable
92
Palma de Mallorca
2024-09-27
By invitation
A Phase I Dose-escalation Trial of Definitive Single Dose Stereotactic Body Radiotherapy in Low-risk Breast Cancer Patients: DESERT I Trial
NCT06671691Breast Cancer Early Stage Breast Cancer (Stage 1-3), SBRT
Universitat de les Illes Balears
Phase 1
15
Palma
2024-09-27
Recruiting
RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
NCT06919341ITP - Immune Thrombocytopenia, Primary Immune Thrombocytopenia (ITP)
Fundación Española de Hematología y Hemoterapía
Observational
1,000
A Coruña, Palma, Barcelona, Terrassa, Bilbao, Torrelavega, Castellon, Algeciras
2024-09-27
Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT06613698Liver Diseases, Alcoholic
DrugGSK4532990
GlaxoSmithKline
Phase 2
393
Barcelona, León, Madrid, Santander, Seville, Valencia, Valladolid, Vigo
2024-09-27
Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT06492616Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
Stemline Therapeutics, Inc.
Phase 3
4,220
Vigo, Seville, Badalona, Sant Cugat del Vallès, Sant Joan Despí, San Cristóbal de La Laguna, Cáceres, Móstoles
2024-09-27
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787Alzheimer Disease
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Majadahonda, Málaga, Lleida, Madrid, Salamanca, Seville, Valladolid, Zaragoza
2024-09-26
Active, closed
Inspiratory Muscle Training in Amateur Athletes
NCT06611969Amateur Athletes
University of Valencia
Not applicable
38
Valencia
2024-09-26
Recruiting
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
NCT06462235Gram-negative Bacterial Infection
Pfizer
Phase 2
48
Madrid
2024-09-25
Active, closed
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
NCT06660394Dravet Syndrome
DrugLP352
Longboard Pharmaceuticals
Phase 3
96
Esplugues de Llobregat, Pamplona, Barcelona, Madrid, Málaga
2024-09-25
Rows per page Showing 2601–2700 of 5885
Previous 25 26 27 28 29 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-spain?page=27

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,885 studies in total at the last sync on 26 Sep 2026, 19:52 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Spain?

3,103 of the 5,885 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:52 UTC sync. A further 504 have not yet opened recruitment, 2,059 are active but closed to new participants, and 219 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (116) Multiple Myeloma (75) Heart Failure (60) Obesity (56) Non-Small Cell Lung Cancer (46) Carcinoma, Non-Small-Cell Lung (45) Non-small Cell Lung Cancer (45) Colorectal Cancer (44) Prostate Cancer (43) Advanced Solid Tumor (43) Ovarian Cancer (39) Multiple Sclerosis (37) Coronary Artery Disease (37) Advanced Solid Tumors (35) Stroke (35)
→

Browse trials by site location

Barcelona (3233) Madrid (3015) Valencia (1201) Seville (1055) Málaga (741) Pamplona (602) Badalona (557) A Coruña (484) L'Hospitalet de Llobregat (446) Córdoba (436) Santander (402) Santiago de Compostela (384) Salamanca (363) Granada (308) Alicante (275)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.